Results for "Mitochondrial DNA"
Conditions Encyclopedia Entry 1779373564
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific type of disorder and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, rather than an inherited one. Diagnosis of MM typically involves a combination of genetic testing, muscle biopsy, and other medical tests. Treatment for MM is often focused on managing symptoms and improving quality of life, as there is currently no cure for the disorder. ### History/Background The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of MM was discovered. In 1988, a team of researchers identified the first mitochondrial DNA mutation associated with a myopathic disorder. Since then, numerous other mutations have been identified, and our understanding of the genetic basis of MM has continued to grow. ### Key Information Mitochondrial Myopathies are a heterogeneous group of disorders, with over 150 different mutations identified to date. The most common types of MM include: * **Kearns-Sayre Syndrome**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), muscle weakness, and cardiac conduction abnormalities. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy. * **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ### Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. While the disorders are rare, they can have a profound impact on the quality of life for those affected. Research into MM has also led to a greater understanding of the role of mitochondria in energy production and the development of new treatments for other disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions), 1988 (identification of first mitochondrial DNA mutation) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Rare Diseases, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Pain, Vision Problems, Hearing Loss, Balance Disorders, Autosomal Dominant Inheritance, Maternal Inheritance, New Mutation, Genetic Testing, Muscle Biopsy, Symptom Management, Quality of Life.
Health & MedicineConditions Encyclopedia Entry 1778558465
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders characterized by the malfunction of the mitochondria, the energy-producing structures within cells. These disorders affect the muscles, nervous system, and other organs, leading to a range of symptoms, including muscle weakness, fatigue, and neurological problems. MM is caused by mutations in the mitochondrial DNA, which is inherited from one's mother. The symptoms and severity of MM can vary greatly depending on the specific mutation and the individual affected. Mitochondrial Myopathies are often classified into several subtypes, including: - **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), pigmentary retinopathy, and heart block. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, ataxia, and muscle weakness. - **NARP Syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa)**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ## History/Background The history of Mitochondrial Myopathies dates back to the 1960s, when the first cases were reported. However, it wasn't until the 1980s that the genetic basis of these disorders was discovered. In 1988, a team of researchers led by Douglas C. Wallace identified the first mitochondrial DNA mutation associated with a mitochondrial myopathy. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. These mutations affect the function of the mitochondria, leading to a range of symptoms, including: - **Muscle weakness**: muscle weakness and wasting are common symptoms of MM. - **Fatigue**: individuals with MM often experience fatigue, which can be debilitating. - **Neurological problems**: MM can cause a range of neurological problems, including seizures, ataxia, and neuropathy. - **Organ dysfunction**: MM can also cause dysfunction of other organs, including the heart, liver, and kidneys. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. These disorders also underscore the importance of genetic testing and counseling for individuals and families affected by MM. Furthermore, research on MM has led to a greater understanding of the role of mitochondria in disease and has opened up new avenues for the development of treatments. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first cases reported) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Neurological Problems, Organ Dysfunction, Genetic Testing, Counseling.
Health & MedicineConditions Encyclopedia Entry 1777409054
** This encyclopedia entry provides an in-depth look at **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare, inherited disorders that affect the mitochondria, the energy-producing structures within cells. MMs are characterized by the accumulation of mutations in the mitochondrial DNA (mtDNA), leading to impaired energy production and cellular dysfunction. This results in a range of symptoms, including muscle weakness, fatigue, and other systemic problems. MMs are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition, and it is usually passed down from the mother. Mitochondrial Myopathies are a diverse group of disorders, with over 150 different mutations identified in the mtDNA. The most common forms of MMs include **Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**, **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, and **Kearns-Sayre Syndrome (KSS)**. Each of these conditions has distinct clinical features and age of onset, but they all share a common underlying defect in mitochondrial function. ## History/Background The study of Mitochondrial Myopathies dates back to the 1960s, when the first cases were described in the medical literature. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of the first mitochondrial DNA mutation in 1988 marked a significant turning point in the field, and since then, numerous studies have shed light on the molecular mechanisms underlying MMs. Today, MMs are recognized as a distinct group of disorders, with a growing body of research focused on understanding their pathophysiology and developing effective treatments. ## Key Information * **Prevalence:** MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Causes:** MMs are caused by mutations in the mitochondrial DNA, which are inherited from the mother. * **Symptoms:** Symptoms of MMs can vary widely, but often include muscle weakness, fatigue, seizures, and other systemic problems. * **Diagnostic tests:** Diagnosis is typically made using a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment:** There is no cure for MMs, but treatment options include medications to manage symptoms, physical therapy, and lifestyle modifications. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. MMs also underscore the complex interplay between genetic and environmental factors in disease development. Furthermore, the study of MMs has led to a greater understanding of the role of mitochondria in various diseases, including neurodegenerative disorders and cancer. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first cases described) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Mitochondrial DNA, Genetic disorder, Muscle weakness, Fatigue, Seizures, Rare disease, Neurodegenerative disorder, Cancer.
Health & MedicineConditions Encyclopedia Entry 1778756960
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare, inherited disorders that affect the mitochondria, the powerhouses of cells. These disorders are caused by mutations in mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including muscles, the nervous system, and other organs. Symptoms can vary widely among individuals, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are often inherited in a maternal lineage, meaning that they are passed down from mother to child. This is because only egg cells contribute mitochondria to the fertilized egg, while sperm cells do not. As a result, mitochondrial DNA is inherited solely from the mother. The disorders can be caused by mutations in any of the 37 genes found in mitochondrial DNA, which are responsible for encoding proteins involved in energy production. ## History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist named Keith Killen described a family with a rare disorder affecting the muscles and nervous system. However, it wasn't until the 1980s that the genetic basis of the disorder was identified. In 1988, a team of researchers led by Douglas C. Wallace discovered that the disorder was caused by a mutation in mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: - **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), which is a weakness of the eye muscles. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by seizures and muscle weakness. - **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. - **Leigh Syndrome**: a disorder characterized by progressive brain damage and muscle weakness. Symptoms of mitochondrial myopathies can vary widely among individuals, but often include: - Muscle weakness and fatigue - Pain and stiffness in the muscles - Difficulty walking or maintaining balance - Seizures and epilepsy - Vision problems, including blindness - Hearing loss - Cognitive impairment and dementia ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on affected individuals and families. While there is currently no cure for these disorders, researchers are working to develop new treatments, including gene therapy and mitochondrial-targeted antioxidants. Understanding the genetic basis of mitochondrial myopathies has also led to a greater appreciation of the importance of mitochondria in human health and disease. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1962 (first reported case) - Location: Worldwide - Known For: Rare inherited disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Inherited Disorders, Muscle Weakness, Fatigue, Pain, Seizures, Epilepsy, Vision Problems, Hearing Loss, Cognitive Impairment.
Health & MedicineConditions Encyclopedia Entry 1779228126
Mitochondrial myopathies are a group of rare genetic disorders characterized by the impaired functioning of the mitochondria, leading to muscle weakness and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA or nuclear DNA that affect the functioning of the mitochondria. Mitochondria are the energy-producing structures within cells, and their dysfunction leads to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. These disorders are often inherited in an autosomal dominant or maternal pattern, meaning they can be passed down from parent to child or inherited solely from the mother. Mitochondrial myopathies can affect individuals of any age, from childhood to adulthood, and can have a significant impact on quality of life. Mitochondrial myopathies are often classified into several subtypes, including Kearns-Sayre syndrome, MELAS syndrome, and myoclonic epilepsy with ragged-red fibers (MERRF). Each subtype has distinct clinical features and genetic mutations. For example, Kearns-Sayre syndrome is characterized by progressive external ophthalmoplegia, cardiac conduction abnormalities, and endocrine dysfunction, while MELAS syndrome is associated with encephalopathy, lactic acidosis, and stroke-like episodes. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production and the impact of their dysfunction on cellular function. The discovery of the mitochondrial DNA in the 1960s and the development of techniques for analyzing mitochondrial DNA in the 1980s led to a greater understanding of the genetic basis of these disorders. Since then, numerous studies have identified the genetic mutations responsible for various subtypes of mitochondrial myopathies. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the functioning of the mitochondria. The most common genetic mutations associated with these disorders include point mutations, deletions, and duplications of mitochondrial DNA. These mutations can lead to impaired energy production, oxidative stress, and cellular damage. Symptoms of mitochondrial myopathies can vary widely depending on the subtype and severity of the disorder. Common symptoms include: * Muscle weakness and fatigue * Exercise intolerance * Muscle pain and cramping * Cardiac conduction abnormalities * Endocrine dysfunction * Neurological symptoms, such as seizures and cognitive impairment Diagnosis of mitochondrial myopathies typically involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific genetic mutation responsible for the disorder, while muscle biopsy can provide information on the extent of mitochondrial dysfunction. ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on quality of life. These disorders can have a profound effect on individuals and families, affecting not only physical health but also emotional and psychological well-being. While there is currently no cure for mitochondrial myopathies, various treatments are available to manage symptoms and slow disease progression. Research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in energy production and the impact of their dysfunction on cellular function. This knowledge has far-reaching implications for the development of treatments for a range of diseases, including neurodegenerative disorders and cancer. INFOBOX: - Name: Mitochondrial Myopathies - Type: Rare Genetic Disorders - Date: 1960s (first reported cases) - Location: Global (affects individuals worldwide) - Known For: Impaired functioning of mitochondria leading to muscle weakness and other systemic symptoms TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, MELAS Syndrome, MERRF, Rare Genetic Disorders, Mitochondrial DNA, Nuclear DNA, Muscle Weakness, Fatigue, Exercise Intolerance.
Health & MedicineConditions Encyclopedia Entry 1775964610
** **Mitochondrial Myopathies** (MMD) are a group of rare genetic disorders characterized by the progressive degeneration of muscle tissue due to mutations in the mitochondrial DNA. **CONTENT:** ## Overview Mitochondrial Myopathies (MMD) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for encoding some of the proteins necessary for energy production. MMDs are characterized by the progressive degeneration of muscle tissue, leading to muscle weakness, fatigue, and other systemic symptoms. The symptoms of MMDs can vary widely depending on the specific mutation and the affected individual, but they often include muscle pain, cramping, and weakness, as well as other systemic symptoms such as gastrointestinal problems, hearing loss, and vision problems. MMDs are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. However, some cases may be caused by spontaneous mutations or by mutations in the nuclear DNA, which can be inherited in an autosomal recessive pattern. The diagnosis of MMDs is often challenging, as the symptoms can be nonspecific and may resemble those of other conditions. However, genetic testing can help identify the underlying mutation and confirm the diagnosis. ## History/Background The first reported case of MMD was in 1962, when a family was identified with a mitochondrial myopathy that was later found to be caused by a mutation in the mitochondrial DNA. Since then, numerous cases of MMD have been reported, and the condition has been recognized as a distinct clinical entity. In the 1980s, the first genetic tests for MMD were developed, allowing for the identification of the underlying mutation and the diagnosis of the condition. Today, MMDs are recognized as a group of rare genetic disorders that affect approximately 1 in 5,000 people worldwide. ## Key Information MMDs are caused by mutations in the mitochondrial DNA, which can affect any of the 37 genes that are encoded by this DNA. The most common mutations associated with MMDs include: * **MELAS syndrome**: A condition characterized by muscle weakness, seizures, and other systemic symptoms. * **MERRF syndrome**: A condition characterized by muscle weakness, ataxia, and other systemic symptoms. * **KSS syndrome**: A condition characterized by muscle weakness, ataxia, and other systemic symptoms. * **NARP syndrome**: A condition characterized by muscle weakness, ataxia, and other systemic symptoms. The symptoms of MMDs can vary widely depending on the specific mutation and the affected individual. Common symptoms include: * Muscle weakness and fatigue * Muscle pain and cramping * Gastrointestinal problems * Hearing loss * Vision problems * Ataxia (loss of coordination and balance) ## Significance MMDs are significant because they highlight the importance of mitochondrial function in maintaining muscle tissue and overall health. The study of MMDs has also led to a greater understanding of the role of mitochondrial DNA in human disease and has provided insights into the development of new treatments for these conditions. Furthermore, MMDs are a reminder of the importance of genetic testing in diagnosing and managing rare genetic disorders. **INFOBOX:** - Name: Mitochondrial Myopathies (MMD) - Type: Rare genetic disorder - Date: 1962 (first reported case) - Location: Worldwide - Known For: Progressive degeneration of muscle tissue due to mutations in the mitochondrial DNA **TAGS:** Mitochondrial Myopathies, MMD, Rare genetic disorder, Mitochondrial DNA, Muscle weakness, Fatigue, Gastrointestinal problems, Hearing loss, Vision problems, Ataxia.
Health & MedicineConditions Encyclopedia Entry 1777363686
** **Mitochondrial Myopathies** are a group of rare genetic disorders characterized by the progressive degeneration of muscle tissue due to defects in the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a collection of rare, inherited disorders that affect the mitochondria, the powerhouses of cells responsible for generating energy. These conditions are caused by mutations in the mitochondrial DNA, which codes for proteins essential for energy production. As a result, muscle cells are unable to produce sufficient energy, leading to progressive muscle weakness, wasting, and degeneration. Mitochondrial Myopathies can affect any muscle group, but the most commonly affected areas are the skeletal muscles, particularly those involved in movement and locomotion. The symptoms of Mitochondrial Myopathies can vary widely depending on the specific condition and the individual affected. Common symptoms include muscle weakness, fatigue, pain, and cramping. In some cases, patients may experience additional symptoms such as seizures, developmental delays, and vision and hearing loss. The progression of the disease can be slow or rapid, and some individuals may experience periods of remission. ### History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the genetic basis of these conditions. In the 1980s, the discovery of the mitochondrial DNA and its role in energy production further clarified the underlying mechanisms of these disorders. Since then, advances in genetic testing and molecular biology have led to a better understanding of the causes and consequences of Mitochondrial Myopathies. ### Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited from either parent or occur spontaneously. There are over 200 known mutations that can cause these conditions, each with its unique set of symptoms and characteristics. Some of the most common types of Mitochondrial Myopathies include: * **Kearns-Sayre Syndrome**: a rare condition characterized by progressive external ophthalmoplegia (PEO), heart block, and muscle weakness. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition that affects the brain and muscles, causing seizures, muscle weakness, and other symptoms. * **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)**: a condition that affects the nervous system, causing muscle weakness, ataxia, and vision loss. ### Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and the impact they have on affected individuals and their families. These conditions can have a profound effect on quality of life, causing significant disability and distress. While there is currently no cure for Mitochondrial Myopathies, advances in genetic testing and molecular biology have led to the development of targeted therapies and supportive care strategies. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first reported cases) - **Location:** Global - **Known For:** Progressive muscle degeneration due to mitochondrial defects **TAGS:** Mitochondrial Myopathies, Rare genetic disorders, Muscle degeneration, Mitochondrial DNA, Kearns-Sayre Syndrome, MERRF, NARP, Genetic testing, Molecular biology.
Health & MedicineConditions Encyclopedia Entry 1778860463
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by a decline in mitochondrial function, leading to muscle weakness, fatigue, and other systemic symptoms. MMs are caused by mutations in mitochondrial DNA, which is inherited from one's mother. The disorders can be classified into different types based on the specific mitochondrial gene affected and the severity of symptoms. Mitochondrial Myopathies can affect individuals of any age, from infancy to adulthood. The symptoms of MMs can vary widely, but common features include muscle weakness, particularly in the muscles of the face, arms, and legs. Other symptoms may include fatigue, shortness of breath, and difficulties with swallowing and speaking. In some cases, MMs can also cause neurological symptoms, such as seizures, vision loss, and hearing loss. ## History/Background The first descriptions of MMs date back to the 1960s, when researchers began to identify cases of mitochondrial myopathies in patients with unexplained muscle weakness. However, it wasn't until the 1980s that the genetic basis of MMs was fully understood. In 1988, a team of researchers led by Dr. Douglas C. Wallace identified the first mitochondrial DNA mutation associated with a mitochondrial myopathy. Since then, numerous studies have identified additional mitochondrial genes and mutations associated with MMs. ## Key Information Mitochondrial Myopathies are caused by mutations in mitochondrial DNA, which is inherited from one's mother. The disorders can be classified into different types based on the specific mitochondrial gene affected and the severity of symptoms. Some common types of MMs include: - **Kearns-Sayre Syndrome**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), which is a condition that affects the muscles controlling eye movement. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by muscle stiffness, seizures, and vision loss. - **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)**: a disorder characterized by muscle weakness, vision loss, and hearing loss. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. The disorders also underscore the importance of genetic testing in diagnosing and managing rare genetic disorders. In addition, research on MMs has led to a greater understanding of the role of mitochondria in energy production and has implications for the development of new treatments for a range of diseases. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first descriptions), 1988 (identification of first mitochondrial DNA mutation) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Neurological Symptoms, Kearns-Sayre Syndrome, MERRF, NARP, Genetic Testing. **When to Seek Professional Care:** If you or a family member is experiencing symptoms of Mitochondrial Myopathies, seek medical attention from a qualified healthcare professional. Early diagnosis and management can help alleviate symptoms and improve quality of life.
Health & MedicineConditions Encyclopedia Entry 1776243964
Mitochondrial myopathies are a group of rare genetic disorders characterized by the accumulation of abnormal **mitochondrial DNA** mutations, leading to impaired energy production in muscle cells and various systemic symptoms.
ScienceBiology Encyclopedia Entry 1778480704
Mitochondrial DNA (mtDNA) is a type of DNA found within the mitochondria of eukaryotic cells, playing a crucial role in the transmission of genetic information related to energy production and cellular respiration. ## Overview Mitochondrial DNA is a unique form of DNA that is separate from the nuclear DNA found in the cell's nucleus. This distinct DNA is responsible for encoding genes that are essential for the proper functioning of the mitochondria, the cell's primary energy-producing organelle. Mitochondrial DNA is a circular molecule, approximately 16.5 kilobases in length, and contains 37 genes that are involved in the production of energy through the process of cellular respiration. The discovery of mitochondrial DNA dates back to the 1960s, when scientists first isolated and characterized this unique form of DNA. Since then, research has focused on understanding the role of mtDNA in energy production, as well as its potential applications in fields such as medicine and forensic science. Mitochondrial DNA has been found to be highly conserved across different species, suggesting a common ancestry and providing valuable insights into the evolution of life on Earth. ## History/Background The study of mitochondrial DNA began in the 1960s, when scientists first isolated and characterized this unique form of DNA. One of the key figures in the discovery of mtDNA was Dr. Elizabeth Sanger, who in 1964 isolated the first mtDNA molecule from the mitochondria of a human cell. This breakthrough discovery paved the way for further research into the structure and function of mtDNA. In the 1970s and 1980s, researchers began to understand the role of mtDNA in energy production and cellular respiration. The discovery of the mitochondrial genome, which contains the 37 genes responsible for encoding proteins involved in energy production, was a major milestone in the field. This knowledge has since been applied in fields such as medicine, where mtDNA mutations have been linked to a range of diseases, including neurodegenerative disorders and metabolic disorders. ## Key Information Mitochondrial DNA is a circular molecule, approximately 16.5 kilobases in length, and contains 37 genes that are involved in the production of energy through the process of cellular respiration. The genes encoded by mtDNA include those responsible for the production of proteins involved in the electron transport chain, as well as those involved in the synthesis of ATP, the primary energy currency of the cell. One of the key features of mtDNA is its high degree of conservation across different species. This suggests a common ancestry and provides valuable insights into the evolution of life on Earth. Mitochondrial DNA has also been used in forensic science to identify individuals and determine their ancestry. ## Significance The study of mitochondrial DNA has significant implications for our understanding of the evolution of life on Earth. The high degree of conservation of mtDNA across different species suggests a common ancestry and provides valuable insights into the history of life on our planet. In addition, the study of mtDNA has applications in fields such as medicine, where mtDNA mutations have been linked to a range of diseases, including neurodegenerative disorders and metabolic disorders. The use of mtDNA in forensic science has also revolutionized the field, allowing for the identification of individuals and determination of their ancestry. INFOBOX: - Name: Mitochondrial DNA - Type: Genetic material - Date: 1964 (first isolated and characterized) - Location: Mitochondria of eukaryotic cells - Known For: Encoding genes involved in energy production and cellular respiration TAGS: Mitochondrial DNA, mtDNA, cellular respiration, energy production, evolution, forensic science, medicine, genetics, molecular biology.
Health & MedicineConditions Encyclopedia Entry 1777609755
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are typically inherited in a maternal lineage, as only egg cells contribute mitochondria to the developing embryo. This means that the condition is passed down from mother to child. There are over 150 known mitochondrial myopathies, each caused by a specific mutation in the mitochondrial DNA. The most common forms of MM include Kearns-Sayre Syndrome (KSS), Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these conditions has distinct symptoms and progression rates, but they all share a common thread: the progressive decline of mitochondrial function. ## History/Background The first reported case of a mitochondrial myopathy was in 1957, when a British neurologist named John N. Walton described a patient with a rare condition characterized by progressive external ophthalmoplegia (PEO) and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of the mitochondrial DNA and its role in energy production paved the way for the identification of the genetic mutations responsible for MM. ## Key Information Mitochondrial Myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Eye movement disorders (e.g., PEO) * Epilepsy and seizures * Hearing loss and vision impairment * Cardiac conduction abnormalities * Cognitive decline and dementia The progression and severity of MM vary widely depending on the specific mutation and individual factors. Some people may experience a slow and gradual decline, while others may experience a more rapid progression. ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and the lack of effective treatments. While there is no cure for MM, researchers are working to develop new therapies that target the underlying genetic mutations. These efforts include gene therapy, mitochondrial-targeted antioxidants, and other innovative approaches. The study of MM has also shed light on the importance of mitochondrial function in overall health and disease. Mitochondria are responsible for producing the majority of the energy that cells need to function, and their dysfunction has been implicated in a wide range of diseases, including cancer, neurodegenerative disorders, and metabolic disorders. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1957 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, fatigue, and other systemic symptoms TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Chronic Progressive External Ophthalmoplegia, Mitochondrial DNA, Genetic Disorders, Rare Diseases, Muscle Weakness, Fatigue, Exercise Intolerance.
Health & MedicineConditions Encyclopedia Entry 1778737984
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. MMs are characterized by muscle weakness, fatigue, and other symptoms related to impaired energy production. The disorders can affect individuals of any age, but they are more common in women due to the way mitochondria are inherited. Mitochondrial Myopathies are often classified into several subtypes, including: - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: characterized by muscle spasms, seizures, and other neurological symptoms. - **Kearns-Sayre Syndrome (KSS)**: characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. - **NARP Syndrome**: characterized by neuropathy, ataxia, and retinitis pigmentosa. - **MELAS Syndrome**: characterized by mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. ## History/Background The first reported case of a mitochondrial myopathy was in 1965, when a British physician, **John Morgan Hughes**, described a patient with progressive external ophthalmoplegia. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production led to a greater understanding of the pathophysiology of MMs. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited from either parent. The disorders can be classified into several subtypes based on the specific mutation and the symptoms presented. Some common symptoms of MMs include: - Muscle weakness and fatigue - Muscle pain and cramping - Seizures and other neurological symptoms - Vision loss and eye problems - Heart problems and arrhythmias - Gastrointestinal problems ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. While there is currently no cure for MMs, various treatments are available to manage symptoms and slow disease progression. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1965 (first reported case) - **Location:** Worldwide - **Known For:** Impaired energy production in cells ## Tags: Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Seizures, Vision Loss, Heart Problems, Gastrointestinal Problems, Genetic Testing, Counseling.
Health & MedicineConditions Encyclopedia Entry 1776704705
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and cellular damage. MMs can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MMs can vary widely depending on the specific type and severity of the disorder. There are several types of Mitochondrial Myopathies, including: * **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia, pigmentary retinopathy, and cardiac conduction defects. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, ataxia, and ragged-red fibers on muscle biopsy. * **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ## History/Background Mitochondrial Myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of mitochondrial DNA mutations as the cause of MMs revolutionized the field of genetics and led to a greater understanding of the role of mitochondria in human disease. ## Key Information * **Prevalence**: Mitochondrial Myopathies are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 people. * **Causes**: MMs are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and cellular damage. * **Symptoms**: The symptoms of MMs can vary widely depending on the specific type and severity of the disorder. Common symptoms include muscle weakness, fatigue, seizures, and vision loss. * **Diagnosis**: Diagnosis of MMs is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment**: There is currently no cure for MMs, but treatment options are available to manage symptoms and slow disease progression. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondria in human health and disease. The study of MMs has led to a greater understanding of the role of mitochondria in energy production and cellular function, and has shed light on the genetic basis of these disorders. Additionally, the study of MMs has led to the development of new treatments and therapies for these disorders. INFOBOX: - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1960s (first described) - Location: Global - Known For: Impaired energy production and cellular damage due to mitochondrial DNA mutations TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Neuropathy, Ataxia, and Retinitis Pigmentosa, Mitochondrial DNA, Energy Production, Cellular Damage, Rare Genetic Disorders, Genetic Testing, Muscle Biopsy.
Health & MedicineConditions Encyclopedia Entry 1777998620
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders occur when there are mutations in the mitochondrial DNA, which codes for proteins essential for energy production. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and difficulty with physical activities. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a mutation in one copy of the mitochondrial DNA is enough to cause the disorder. This is because only egg cells contribute mitochondria to the fertilized egg, making mitochondrial DNA inherited solely from the mother. The disorders can also occur spontaneously, without a family history. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to understand the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of mitochondrial DNA mutations led to a greater understanding of the underlying causes of these disorders and paved the way for diagnostic testing. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: - **Muscle weakness**: Muscle weakness is a common symptom of mitochondrial myopathies, particularly in the muscles of the face, arms, and legs. - **Fatigue**: Fatigue is another common symptom, which can be debilitating and affect daily activities. - **Difficulty with physical activities**: Patients with mitochondrial myopathies may experience difficulty with physical activities, such as walking or climbing stairs. - **Vision problems**: Some patients may experience vision problems, including blurred vision or loss of vision. - **Cognitive impairment**: Cognitive impairment, including memory loss and difficulty with concentration, can occur in some patients. There are several types of mitochondrial myopathies, including: - **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: This is a severe form of mitochondrial myopathy that affects the brain, muscles, and other organs. - **Myoclonic epilepsy with ragged-red fibers (MERRF)**: This disorder affects the muscles and nervous system, causing muscle weakness, seizures, and other symptoms. - **Kearns-Sayre syndrome**: This disorder affects the muscles, nervous system, and other organs, causing muscle weakness, vision problems, and other symptoms. ## Significance Mitochondrial myopathies are rare disorders that affect a small number of people worldwide. However, they have significant implications for patients and families affected by these disorders. The diagnosis of mitochondrial myopathies can be challenging, and it often requires a combination of clinical evaluation, genetic testing, and other diagnostic tests. The significance of mitochondrial myopathies lies in their impact on patients and families. These disorders can have a profound effect on quality of life, causing significant disability and affecting daily activities. However, with advances in diagnostic testing and treatment, patients with mitochondrial myopathies can receive more effective care and management. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Energy Production, Mitochondrial DNA, Autosomal Dominant, Maternal Inheritance, Muscle Weakness, Fatigue, Vision Problems, Cognitive Impairment, Rare Disorders.
Health & MedicineConditions Encyclopedia Entry 1776636424
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific condition and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance. Mitochondrial myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some forms of MM can be inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to cause the condition. The diagnosis of MM is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### History/Background Mitochondrial myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of these conditions. Since then, numerous studies have been conducted to better understand the causes and consequences of MM. In 1991, the first mitochondrial DNA mutation was identified as the cause of a specific form of MM. Today, over 150 different mitochondrial DNA mutations have been identified as causing MM. ### Key Information Mitochondrial myopathies are a group of rare conditions, affecting approximately 1 in 5,000 people worldwide. The most common forms of MM are: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. Other forms of MM include **Leigh Syndrome**, **NARP Syndrome**, and **Pearson Syndrome**, each with distinct symptoms and characteristics. ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. These conditions also underscore the importance of genetic testing and diagnosis in identifying and managing rare genetic disorders. Furthermore, research into MM has led to a greater understanding of the role of mitochondria in energy production and has implications for the treatment of various other conditions, including cancer and neurodegenerative diseases. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First described in the 1960s - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and other symptoms. **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Pain, Vision Loss, Hearing Loss, Balance Problems, Genetic Testing, Diagnosis.
Health & MedicineConditions Encyclopedia Entry 1782342966
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. Mitochondria are the powerhouses of cells, responsible for generating energy in the form of ATP (adenosine triphosphate). In individuals with mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to muscle weakness, fatigue, and other systemic symptoms. These disorders can affect any muscle group, but the muscles of the face, eyes, and limbs are commonly affected. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms of mitochondrial myopathies can vary widely, even within the same family. Some individuals may experience mild symptoms, while others may experience more severe symptoms that significantly impact their quality of life. ## History/Background The first cases of mitochondrial myopathies were described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of these disorders. Since then, numerous studies have identified the genetic mutations responsible for mitochondrial myopathies and developed diagnostic tests to detect these mutations. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a subtype characterized by seizures, muscle weakness, and lactic acidosis. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a subtype characterized by seizures, muscle weakness, and ragged-red fibers (abnormal muscle fibers) on muscle biopsy. * **Kearns-Sayre syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia (weakness of the eye muscles), heart block, and pigmentary retinopathy. * **Leigh syndrome**: a subtype characterized by progressive brain damage, muscle weakness, and lactic acidosis. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining muscle and overall health. These disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these disorders. Early diagnosis and treatment can significantly improve the quality of life for individuals with mitochondrial myopathies. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first cases described) - Location: Global (affecting individuals worldwide) - Known For: Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Lactic Acidosis, MELAS, MERRF, KSS, Leigh Syndrome, Mitochondrial DNA, Nuclear DNA.
Health & MedicineConditions Encyclopedia Entry 1775477045
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These disorders affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are inherited in a maternal lineage, meaning they are passed down from mother to child. The symptoms and severity of MM can vary widely among individuals, depending on the specific mutation and the extent of mitochondrial dysfunction. Mitochondrial Myopathies are characterized by impaired energy production in cells, leading to muscle weakness, fatigue, and other systemic symptoms. The symptoms of MM can include muscle pain, weakness, and wasting, particularly in the muscles of the face, neck, and limbs. Other symptoms may include seizures, developmental delays, and visual and hearing impairments. In some cases, MM can lead to life-threatening complications, such as respiratory failure and cardiac arrest. ## History/Background Mitochondrial Myopathies were first described in the 1960s, when researchers identified a group of patients with muscle weakness and fatigue who had abnormal mitochondrial function. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. In 1988, the first mitochondrial DNA mutation was identified as the cause of MM. Today, over 150 mitochondrial DNA mutations have been associated with MM, and researchers continue to explore the genetic and molecular mechanisms underlying these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is inherited from the mother. These mutations can occur in any of the 37 genes that encode proteins involved in energy production. The most common mutations associated with MM are those that affect the genes encoding for the respiratory chain complexes, which are essential for energy production in cells. Other key information about MM includes: * **Inheritance pattern:** Mitochondrial Myopathies are inherited in a maternal lineage, meaning they are passed down from mother to child. * **Symptoms:** Muscle weakness, fatigue, muscle pain, seizures, developmental delays, visual and hearing impairments. * **Diagnosis:** Diagnosis is based on a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment:** There is no cure for MM, but treatment options may include physical therapy, speech therapy, and medications to manage symptoms. ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and severity. According to the National Institutes of Health (NIH), MM affects approximately 1 in 5,000 people worldwide. The significance of MM lies in its impact on individuals and families affected by the disorder. MM can have a profound impact on quality of life, leading to significant disability and mortality. Additionally, MM highlights the importance of understanding the genetic and molecular mechanisms underlying complex diseases, which can inform the development of new treatments and therapies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorder - Date: First described in the 1960s - Location: Worldwide - Known For: Impaired energy production in cells leading to muscle weakness and fatigue **TAGS:** Mitochondrial Myopathies, Rare genetic disorders, Mitochondrial DNA, Energy production, Muscle weakness, Fatigue, Seizures, Developmental delays, Visual and hearing impairments.
Health & MedicineConditions Encyclopedia Entry 1780391348
** This encyclopedia entry is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. ## Overview Erythromelalgia is a rare genetic disorder that affects approximately 1 in 200,000 people worldwide. It is characterized by recurring episodes of burning pain, redness, and heat in the hands and feet. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be caused by a genetic mutation, trauma, or certain medications. The symptoms can vary in severity and may be triggered by physical activity, stress, or exposure to heat. People with erythromelalgia may experience a range of symptoms, including: * Burning pain in the hands and feet * Redness and heat in the affected areas * Increased sensitivity to temperature changes * Numbness or tingling in the hands and feet * Fatigue and weakness In some cases, erythromelalgia can be a symptom of an underlying condition, such as **Multiple Sclerosis** or **Diabetes**. If you are experiencing symptoms of erythromelalgia, it is essential to seek medical attention to rule out any underlying conditions. ## History/Background Erythromelalgia was first described in the medical literature in the 19th century. The condition was initially thought to be a rare form of **Raynaud's disease**, but it was later recognized as a distinct entity. In the 1960s, researchers discovered that erythromelalgia was caused by a genetic mutation that affects the **Mitochondrial DNA**. This discovery led to a better understanding of the condition and the development of new treatments. ## Key Information Erythromelalgia is a complex condition that requires a multidisciplinary approach to diagnosis and treatment. The following are some key facts about erythromelalgia: * **Genetic causes**: Erythromelalgia can be caused by a genetic mutation that affects the mitochondrial DNA. * **Symptom management**: Treatment for erythromelalgia focuses on managing symptoms, such as pain and heat. * **Medications**: Certain medications, such as **Anticonvulsants** and **Antidepressants**, may be used to manage symptoms. * **Lifestyle modifications**: People with erythromelalgia may need to make lifestyle modifications, such as avoiding heat and stress. ## Significance Erythromelalgia is a rare condition that affects a small number of people worldwide. However, it has significant implications for those affected, as it can impact daily life and quality of life. The condition highlights the importance of genetic research and the need for better understanding of rare genetic disorders. **INFOBOX:** - Name: Erythromelalgia - Type: Rare genetic disorder - Date: 19th century (first described) - Location: Worldwide - Known For: Recurring episodes of burning pain, redness, and heat in the hands and feet **TAGS:** Rare genetic disorder, Mitochondrial DNA, Erythromelalgia, Raynaud's disease, Multiple Sclerosis, Diabetes, Anticonvulsants, Antidepressants, Lifestyle modifications.
Health & MedicineConditions Encyclopedia Entry 1779205399
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial Myopathies (MM) are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the mitochondria's ability to produce energy. Mitochondria are the powerhouses of cells, responsible for generating adenosine triphosphate (ATP), the primary energy source for cellular functions. In MM, the impaired energy production leads to muscle weakness, fatigue, and other systemic symptoms. These disorders can affect various organs and tissues, including the nervous system, heart, and gastrointestinal tract. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. The disorders can be classified into several subtypes, including: - **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)**: characterized by seizures, muscle weakness, and lactic acidosis. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: marked by myoclonic seizures, muscle weakness, and ragged-red fibers in muscle biopsies. - **Kearns-Sayre Syndrome (KSS)**: characterized by progressive external ophthalmoplegia, muscle weakness, and cardiac conduction abnormalities. - **Leigh Syndrome**: a severe disorder affecting the nervous system, characterized by seizures, muscle weakness, and developmental delays. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1963, when a British neurologist, John Walton, described a patient with a rare disorder characterized by muscle weakness, seizures, and lactic acidosis. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of mitochondrial DNA mutations in patients with MM marked a significant breakthrough in understanding the pathogenesis of these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the expression of mitochondrial genes. These mutations can lead to impaired energy production, oxidative stress, and cellular damage. The disorders can be diagnosed through a combination of clinical evaluation, muscle biopsy, and genetic testing. Key features of Mitochondrial Myopathies include: - **Muscle weakness**: progressive muscle weakness, particularly in the proximal muscles. - **Fatigue**: persistent fatigue, even after rest. - **Lactic acidosis**: elevated levels of lactic acid in the blood. - **Seizures**: seizures, particularly in MELAS and MERRF subtypes. - **Developmental delays**: delayed development in children with Leigh Syndrome. ## Significance Mitochondrial Myopathies are rare disorders with significant impact on patients and their families. The disorders can be challenging to diagnose and manage, requiring a multidisciplinary approach involving neurologists, geneticists, and other specialists. Early diagnosis and treatment can improve quality of life and slow disease progression. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First reported case in 1963 - **Location:** Global - **Known For:** Impaired energy production and systemic symptoms **TAGS:** Mitochondrial Myopathies, Mitochondrial DNA, Nuclear DNA, Energy production, Muscle weakness, Fatigue, Lactic acidosis, Seizures, Developmental delays, Rare genetic disorders.
Health & MedicineConditions Encyclopedia Entry 1778688320
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies are often inherited in an **autosomal** pattern, meaning that a person can inherit the mutated gene from either parent. However, some cases can also occur spontaneously due to new mutations. The disorders can affect people of all ages, but they are more common in women due to the way in which mitochondrial DNA is inherited. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. In the 1980s, scientists discovered the first mitochondrial DNA mutations associated with these disorders. Since then, numerous studies have identified many different mutations that can cause mitochondrial myopathies. ## Key Information There are several types of mitochondrial myopathies, including: - **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: This is one of the most common forms of mitochondrial myopathy, characterized by episodes of stroke-like symptoms, lactic acidosis, and other systemic problems. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: This disorder is characterized by muscle weakness, seizures, and other systemic problems. - **Kearns-Sayre Syndrome (KSS)**: This disorder is characterized by progressive external ophthalmoplegia, heart block, and other systemic problems. ## Significance Mitochondrial myopathies are significant because they can have a major impact on a person's quality of life. The disorders can cause significant muscle weakness, fatigue, and other systemic problems, which can affect a person's ability to perform daily activities. In some cases, the disorders can also be life-threatening. Research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in energy production and the importance of mitochondrial DNA in maintaining cellular function. This research has also led to the development of new treatments and therapies for these disorders. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Systemic Problems, Autosomal Inheritance, MELAS, MERRF, KSS.